Despite recently-imposed lockdowns, FY20/21 guidance maintained driven by Paradise
17/11/20 -"The H1 20/21 beat was driven by a strong market rebound, robust commercial execution and the successful launch of Paradise. The hearing aid wholesale business fared better than retail, though ..."
Pages
60
Language
English
Published on
17/11/20
You may also be interested by these reports :
23/10/25
Sartorius Stedim Biotech reported an estimate-beating Q3 2025. Revenue was up 12.0%, driven almost entirely by the high-margin consumables business. ...
22/10/25
Sartorius delivered a robust Q3 2025 performance, beating consensus on both revenue and EBITDA, though slightly missing our EBITDA estimate. Revenue ...
20/10/25
“Only when the tide goes out do you discover who’s been swimming naked.” This famous line from Warren Buffett fits well for the ...
20/10/25
Despite a significant downgrade in our estimates, our strong buy recommendation for Elekta remains unchanged. This is supported by ongoing ...